Search

everythinglearnresearchcommunity

for

Search:↓

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

Acne keloidalis nuchae is a chronic skin condition more common in African men, causing itchy or painful bumps and can lead to permanent hair loss if not treated early.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Early diagnosis and less aggressive hair care improve outcomes for Black women with frontal fibrosing alopecia.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Growth factors and microneedle therapy increase hair density in women with hair loss.

External factors like pollution, stress, and poor nutrition can negatively affect hair growth.

More research is needed to understand alopecia areata severity.

Certain symptoms and patient profiles, like thoracic pain and general malaise, increase the risk of COVID-19 patients being readmitted to the emergency department.

MSCs help rejuvenate skin by promoting cell growth and reducing inflammation.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

AI can improve early diagnosis and classification of PCOS, aiding in prevention of related health issues.

Poliosis is common in severe alopecia areata but doesn't significantly affect overall prognosis.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

Physical activity, height, and smoking affect prostate cancer risk.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.